Novo co-led a second tranche that lifted Metagenomi’s series B round to $275m while crypto payment technology provider Wyre is shutting after a $1.5bn acquisition fell through.

M&A Pharmaceutical firm Moderna has agreed to pay $85m to acquire OriCiro Genomics, a Japan-based developer of cell-free synthesis technology, allowing trading group Itochu and pharmaceutical company Asahi Kasei to exit. Coprorate venturing unit Itochu Technology Ventures took part in a $7.3m series B round in mid-2021 that increased the total raised by OriCiro to…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.